• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Korean Med Sci . Maternal and Neonatal Outcomes in Pregnant Women With Coronavirus Disease 2019 in Korea

tetano

Editor, Senior Moderator
J Korean Med Sci


. 2022 Oct 24;37(41):e297.
doi: 10.3346/jkms.2022.37.e297.
Maternal and Neonatal Outcomes in Pregnant Women With Coronavirus Disease 2019 in Korea


Youseung Chung[SUP] 1 [/SUP], Eun Jin Kim[SUP] 2 [/SUP], Hee-Sung Kim[SUP] 3 [/SUP], Kyung-Hwa Park[SUP] 4 [/SUP], Ji Hyeon Baek[SUP] 5 [/SUP], Jungok Kim[SUP] 6 7 [/SUP], Ji Yeon Lee[SUP] 8 [/SUP], Chang-Seop Lee[SUP] 9 [/SUP], Seungjin Lim[SUP] 10 [/SUP], Shin-Woo Kim[SUP] 11 [/SUP], Eu Suk Kim[SUP] 12 [/SUP], Hye Jin Shi[SUP] 13 [/SUP], Shin Hee Hong[SUP] 13 [/SUP], Jae-Bum Jun[SUP] 14 [/SUP], Kyung-Wook Hong[SUP] 15 [/SUP], Jae-Phil Choi[SUP] 16 [/SUP], Jinyeong Kim[SUP] 17 [/SUP], Kyung Sook Yang[SUP] 18 [/SUP], Young Kyung Yoon[SUP] 19 [/SUP]



Affiliations

Abstract

Background: This study aimed to describe the maternal, obstetrical, and neonatal outcomes in pregnant women with coronavirus disease 2019 (COVID-19) and identify the predictors associated with the severity of COVID-19.
Methods: This multicenter observational study included consecutive pregnant women admitted because of COVID-19 confirmed using reverse transcriptase-polymerase chain reaction (RT-PCR) test at 15 hospitals in the Republic of Korea between January 2020 and December 2021.
Results: A total of 257 women with COVID-19 and 62 newborns were included in this study. Most of the patients developed this disease during the third trimester. Nine patients (7.4%) developed pregnancy-related complications. All pregnant women received inpatient treatment, of whom 9 (3.5%) required intensive care, but none of them died. The gestational age at COVID-19 diagnosis (odds ratio [OR], 1.096, 95% confidence interval [CI], 1.04-1.15) and parity (OR, 1.703, 95% CI, 1.13-2.57) were identified as significant risk factors of severe diseases. Among women who delivered, 78.5% underwent cesarean section. Preterm birth (38.5%), premature rupture of membranes (7.7%), and miscarriage (4.6%) occurred, but there was no stillbirth or neonatal death. The RT-PCR test of newborns' amniotic fluid and umbilical cord blood samples was negative for severe acute respiratory syndrome coronavirus 2.
Conclusion: At the time of COVID-19 diagnosis, gestational age and parity of pregnant women were the risk factors of disease severity. Vertical transmission of COVID-19 was not observed, and maternal severity did not significantly affect the neonatal prognosis.

Keywords: Coronavirus Disease 2019; Neonate; Pregnancy; Severe Acute Respiratory Syndrome Coronavirus 2.
 
Back
Top Bottom